LDS/Medical Tests/Phosphorus (Phosphate), 24 Hour, Urine

Phosphorus (Phosphate), 24 Hour, Urine

Inorganic Phosphorus is an important, abundant mineral in the body. Phosphorus, along with calcium, functions to build stronger bones and teeth. It is also needed for DNA production and cell and tissue repair. Serum phosphate concentrations are dependent on parathyroid gland function, kidney function, absorption in the intestine, bone and cell metabolism, and diet. Phosphorus concentrations vary in a diurnal pattern throughout the day. Higher levels are seen in the morning and lower levels at night. Phosphorus levels are 30-50% higher in infants and children, most likely due to the increased bone growth at this age level.

Normal serum phosphorus levels depend on kidney function, as the majority of filtered phosphate is reabsorbed in the proximal tubules. When there is kidney disease or insufficiency, hyperphosphatemia (increased serum phosphorus) occurs. Hyperphosphatemia is also the result of hypoparathyroidism, pseudohypoparathyroidism, excessive oral phosphorus, diabetic ketoacidosis, and systemic infections. There are usually no symptoms of hyperphosphatemia, but when increased calcium is also present, tetany (involuntary muscle contractions) can occur. Hypophosphatemia (decreased phosphorus) is often seen in alcoholism, burns, and heart failure. Severe hypophosphatemia can be seen in starvation or malnutrition. Decreased phosphorus has adverse symptoms such as respiratory failure, heart failure, or coma. Phosphorus analysis is usually performed in conjunction with calcium and other kidney function tests for a complete clinical picture.

  • Diagnostically significant in many clinical situations
  • Used as a monitoring agent with the overall clinical picture in regards to hypo/hyperphosphatemia
  • Aids in diagnosis of renal disease
  • Aids in diagnosis of bone disease
  • Aids in diagnosis of parathyroid disease
  • Aids evaluation of tetany
  • Aids evaluation of seizures
  • Aids evaluation of hypotension

Increased in:

  • Renal failure
  • Calcific uremic arteriolopathy (calciphylaxis)
  • Tumor lysis syndrome
  • Massive blood transfusion
  • Hypoparathyroidism
  • Adrenal insufficiency
  • Vitamin D intoxication
  • Osteolytic metastases to bone
  • Myelogenous leukemia
  • Healing bone fractures
  • Pseudohypoparathyroidism
  • Diabetes mellitus with ketosis
  • Cirrhosis, lactic acidosis
  • Respiratory acidosis
  • Sarcoidosis
  • Milk-Alkali syndrome
  • Acromegaly
  • Portal cirrhosis
  • Lactic acidosis
  • Pulmonary embolism
  • Use of certain drugs: enemas, anabolic steroids, ergocalciferol, furosemide, hydrochlorothiazide, clonidine, verapamil, and others

Decreased in:

  • Primary Hyperparathyroidism
  • PTH-producing tumors
  • Decreased Vitamin D (rickets, osteomalacia)
  • Malabsorption
  • Malnutrition, starvation
  • Bone marrow transplantation
  • Growth Hormone deficiency
  • Chronic alcoholism
  • Severe diarrhea
  • Vomiting
  • Nasogastric suction
  • Acute pancreatitis
  • Severe hypercalcemia (any cause)
  • Acute gout
  • Osteoblastic metastases to bone
  • Severe burns (diuretic phase)
  • Respiratory alkalosis
  • Respiratory infections
  • Acid–base disturbances
  • Hypokalemia
  • Pregnancy
  • Hypothyroidism
  • Osteomalacia
  • Renal tubular defects, e.g., Fanconi syndrome
  • Familial hypocalciuric hypercalcemia
  • Salicylate poisoning
  • Hyperinsulinemia (treatment of diabetes mellitus)

Units: mg/dL / mmol/L

Serum (Age / Sex) mg/dL mmol/L
0–9 days 4.5–9.0 1.45–2.91
10 days–2 yr 4.0–6.5 1.29–2.10
3–9 yr 3.2–5.8 1.03–1.87
10–15 yr 3.3–5.4 1.07–1.74
16–59 yr 2.4–4.4 0.78–1.42
60–89 yr M 2.3–3.7 0.74–1.20
60–89 yr F 2.8–4.0 0.90–1.26
89 yr M 2.2–3.9 0.71–1.26
89 yr F 2.5–4.2 0.81–1.36

 

Urine, Random mg/dL mmol/L
Adult M 5–189 1.6–61
Adult F 7–148 2.3–48

 

Urine, 24 hr g/day mmol/day
Constant daily diet <1.0 <32.3
Non-restricted diet 0.4–1.3 12.9–42.0

*Constant daily diet: 0.9–1.5 g phosphorus [29–48 mmol phosphorus] and 10 mg calcium/kg [0.25 mmol calcium/kg].

Phosphomolybdate-colorimetric; modified molybdate-enzymatic, colorimetric

Urine 24 hours collected in a sterile urine container. 

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Comprehensive Metabolic panel to include Anion Gap, Renal Panel, Kidney Stone Analysis if appropriate, Parathyroid Hormone, Serum Vitamin D, Serum & Urine Calcium, Growth Hormone, Cortisol, PTHRP, Liver panel.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Health Syst Pharm. 2005;62:2355. [PMID: 16278327]
  • Nat Clin Pract Nephrol. 2006;2:136. [PMID: 16932412]
  • Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • Revision: Lewis JL. Disorders of Phosphate Concentration. Retrieved October 9, 2010, from Merck Manuals Online Library: www.merck.com (2009, May)
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008)
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757